Federal Register of Legislation - Australian Government

Primary content

Other as made
This instrument amends the Poisons Standard February 2020 in relation to the substances hydroxychloroquine and salbutamol, principally to ensure the continued availability of medicines containing these substances in Australia during the public health emergency caused by the outbreak of the disease known as coronavirus disease (COVID-19).
Administered by: Health
Registered 23 Mar 2020
Date of repeal 25 Mar 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020

I, Tony Gill, as delegate of the Secretary of the Department of Health, make the following instrument.

Dated 23 March 2020

Tony Gill

Principal Medical Adviser

Prescription Medicines Authorisation Branch

Health Products Regulation Group

Department of Health

 


Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

Part 1—Hydroxychloroquine                                                                                  2

Poisons Standard February 2020                                                                                                      2

Part 2—Salbutamol                                                                                                  3

Poisons Standard February 2020                                                                                                      3

 

 


1  Name

                   This instrument is the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1. The whole of this instrument

The day after this instrument is registered.

24 March 2020

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

Part 1—Hydroxychloroquine

Poisons Standard February 2020

1  Schedule 4 of Part 4 of Schedule 2 (entry for hydroxychloroquine)

Repeal the entry, substitute:

# HYDROXYCHLOROQUINE.

2  At the end of Appendix D of Part 5 of Schedule 2

            Add:

 

8.

Poisons for which the initial treatment of a patient has been authorised following the commencement of the Poisons Standard Amendment (Hydroxychloroquine and Salbutamol) Instrument 2020 by a medical practitioner, recognised under State or Territory legislation that forms part of the Health Practitioner Regulation National Law, as a specialist in any of the following specialties:

(a) dermatology;

(b) intensive care medicine;

(c) paediatrics and child health;

(d) physician;

(e) emergency medicine.

 

HYDROXYCHLOROQUINE.

3  Schedule 2 (index)

Omit the entry for hydroxychloroquine, substitute:

HYDROXYCHLOROQUINE

Schedule 4
Appendix D, Item 8

Part 2—Salbutamol

Poisons Standard February 2020

4  Schedule 3 of Part 4 of Schedule 2 (entry for salbutamol)

Repeal the entry, substitute:

SALBUTAMOL as the only therapeutically active substance:

a)   in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or

b)   in dry powders for inhalation delivering 200 micrograms or less of salbutamol per dose; and

where supply is limited:

c)   to persons with evidence of a medically diagnosed lung condition; or

d)   to persons with a record of previous supply from the pharmacist; or

e)   to persons authorised under a law of a State or Territory to use or supply salbutamol in the practice of their profession; or

f)   for use in institutional first aid; and

where paragraph (c) or (d) applies—supply is limited to one primary pack of salbutamol per person.